Search
for
Sort by
Research 301–330 of 1000+
- A young male with kidney damage from genetic mitochondrial disease: case report and literature review
- Biomedical applications of organoids in genetic diseases
- Bridging Personal and Population in Excitability Diseases: Will Studies of Rare Diseases Bring Generalizable Mechanisms From Monogenic Channelopathies?
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Acrodermatitis Dysmetabolica with Concomitant Acquired Acrodermatitis Enteropathica in a Patient with Maple Syrup Urine Disease
- Biological Activities of 2,3,5,4′-Tetrahydroxystilbene-2-O-<i>β</i>-D-Glucoside in Antiaging and Antiaging-Related Disease Treatments
- Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Plant-derived exosome-like nanovesicles: a novel therapeutic perspective for skin diseases
- Implication of Human Bacterial Gut Microbiota on Immune-Mediated and Autoimmune Dermatological Diseases and Their Comorbidities: A Narrative Review
- The Important Role of Leptin in Modulating the Risk of Dermatological Diseases
- Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
- The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Skin Sceneries of Thyroid Disorders and Impact of Thyroid on Different Skin Diseases: A Scoping Review Focused on Pediatric Patients
- Molecular Morbidity Score–Can MicroRNAs Assess the Burden of Disease?
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
- Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
- Three-Dimensional Organoid System Transplantation Technologies in Future Treatment of Central Nervous System Diseases
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases
- Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease